Showing 1-10 of 32 grants

Title Institution Researcher Program Duration Total Award Amount
Artificial Intelligence-driven redesign of beta cell regulatory logic for resilience to inflammation University of Massachusetts Medical School Rene Maehr Cures 01-April-2026 to 31-March-2027 $199.999,88
Harnessing Neonatal Regulatory T Cells for Precision Immunotherapy in Type 1 Diabetes Boston Children’s Hospital Ayano Kohlgruber Cures 01-March-2026 to 28-February-2031 $998.713,47
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes Massachusetts General Hospital Mark Poznansky Cures 01-February-2026 to 31-January-2028 $599.448,76
Subcutaneous In Vivo Engraftment and Vascularization of 3D Bioprinted Pancreatic-Like Tissue FluidForm Bio Adam Feinberg Cures 23-December-2025 to 12-June-2026 $228.696,00
Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model Blue Circle Health Leonard D’Avolio Mission 01-January-2026 to 31-December-2028 $1.500.000,00
GNTI-122 for the treatment of recently diagnosed type 1 diabetes GentiBio Mark Bach Cures 01-December-2025 to 30-November-2027 $4.000.000,00
Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk Boston Children’s Hospital Juan Melero-Martin Cures 01-November-2025 to 31-October-2027 $599.994,46
ALIGN-T1D Start-Up Secretariat Clinton Health Access Initiative (CHAI) Colin Brown Mission 01-October-2025 to 31-March-2027 $822.000,00
A Cure for Type 1 Diabetes University of Massachusetts Medical School David Harlan Cures 01-October-2025 to 30-September-2029 $16.000.000,00
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 31-August-2026 $150.000,00